文献速递肿瘤 PET/CT核素与放射性配体治疗

68Ga-PSMA PET/CT用于鼻腔鼻窦血管球周细胞瘤诊疗一体化探索

68Ga-Prostate-Specific Membrane Antigen PET/CT in Sinonasal Glomangiopericytoma-Exploring Theranostic Avenues!
PubMed 文献 · Clin Nucl Med · 2021-01-01

本文报道一例25岁男性复发性鼻腔鼻窦血管球周细胞瘤患者,行全身68Ga-PSMA PET/CT检查以探索其诊疗一体化价值。肿瘤显示强烈PSMA摄取(SUVmax=23.9),高于唾液腺、泪腺、主动脉、脾脏和肝脏。该应用为影像学诊断、早期复发识别及可能的放射性配体治疗开辟了新方向。

要点

  • 鼻腔鼻窦血管球周细胞瘤可呈强烈PSMA摄取,SUVmax达23.9。
  • 肿瘤PSMA摄取高于唾液腺、泪腺、主动脉、脾脏和肝脏。
  • PSMA PET/CT有望用于该肿瘤的早期复发识别及放射性配体治疗探索。

核心结论

  • PSMA在多种非前列腺良恶性肿瘤的肿瘤相关内皮新生血管中表达,鼻腔鼻窦血管球周细胞瘤亦显示强烈PSMA摄取。

研究设计与样本

  • 个案报道:一例25岁男性复发性鼻腔鼻窦血管球周细胞瘤患者行全身68Ga-PSMA PET/CT检查。

主要发现

  • 肿瘤内可见强烈PSMA摄取,SUVmax=23.9。
  • 肿瘤PSMA摄取高于唾液腺、泪腺、主动脉、脾脏和肝脏。

临床怎么用

  • PSMA PET/CT可用于鼻腔鼻窦血管球周细胞瘤的影像学评估和早期复发识别。
  • PSMA PET/CT可能为残留或复发肿瘤的放射性配体治疗提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prostate-specific membrane antigen (PSMA) is expressed in the tumor-associated endothelial neovasculature of various nonprostatic benign and malignant neoplasms. A 25-year-old man with recurrent sinonasal glomangiopericytoma underwent whole-body 68Ga PSMA PET/CT to explore its theranostic role. There was intense PSMA uptake (SUVmax = 23.9) noted in the tumor. The uptake was more than that of the salivary glands, lacrimal glands, aorta, spleen, and the liver. Performance of PSMA PET/CT in sinonasal glomangiopericytoma opens up new frontiers concerning radiological imaging, early recurrence identification, and perhaps even radioligand therapy of residual/recurrent tumors.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sakthivel P, Kumar A, Arunraj ST, et al. 68Ga-Prostate-Specific Membrane Antigen PET/CT in Sinonasal Glomangiopericytoma-Exploring Theranostic Avenues! Clin Nucl Med. 2021. PMID: 33323738. doi:10.1097/RLU.0000000000003467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。